Corbus Pharmaceuticals Holdings, Inc. (CRBP)
NASDAQ · Healthcare
Corbus Pharmaceuticals Holdings, Inc. Long Term Debt 2015–2022
Corbus Pharmaceuticals Holdings, Inc. annual/quarterly long term debt history from 2020 to 2022. Long term debt refers to financial obligations that are due more than one year in the future.
- Corbus Pharmaceuticals Holdings, Inc. long term debt for the quarter ending December 31, 2022 were 21.6M, a 1.89% increase year-over-year.
- Corbus Pharmaceuticals Holdings, Inc. long term debt for 2022 were 21.6M, a 1.89% increase from 2021.
- Corbus Pharmaceuticals Holdings, Inc. long term debt for 2021 were 21.2M, a 0.00% increase from 2020.
- Corbus Pharmaceuticals Holdings, Inc. long term debt for 2020 were 21.2M.
Long Term Debt
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Corbus Pharmaceuticals Holdings, Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2022 | $22 |
| 2021 | $21 |
| 2020 | $21 |
| Corbus Pharmaceuticals Holdings, Inc. Quarterly Long Term Debt (Millions of US $) | |
|---|---|
| 2022-12-31 | $22 |
| 2021-12-31 | $21 |
| 2020-12-31 | $21 |
Corbus Pharmaceuticals Holdings, Inc. Long Term Debt — FAQ
Corbus Pharmaceuticals Holdings, Inc. (CRBP) long term debt over the last 8 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CRBP's long term debt history?
The chart and table above show Corbus Pharmaceuticals Holdings, Inc.'s long term debt by year and by quarter, including the growth rate.